Trials / Completed
CompletedNCT01997112
PAracetamol Treatment in Hypertension: Effect on Blood Pressure (PATH-BP) Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- University of Edinburgh · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine if chronic paracetamol dosing increases blood pressure in patients with known high blood pressure.
Detailed description
A prospective randomised, double-blind, crossover trial, comparing the effects of paracetamol 1g (500mg x2) four times daily with matched placebo on ambulatory and clinic BP, each given for 14 days, with a 14-day washout period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paracetamol | |
| DRUG | Placebo oral capsule |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2019-06-04
- Completion
- 2019-10-01
- First posted
- 2013-11-27
- Last updated
- 2019-10-02
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01997112. Inclusion in this directory is not an endorsement.